Suppr超能文献

微小 RNA-217 在透明细胞肾细胞癌中下调,与较低的生存率相关,可抑制细胞增殖和迁移。

MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration.

机构信息

Foshan Maternal and Child Health Care Hospital, Foshan, China.

出版信息

Neoplasma. 2013;60(5):511-5. doi: 10.4149/neo_2013_066.

Abstract

Aberrantly expressed microRNAs (miRNAs) are frequently correlated with a variety of human cancers, including clear cell renal cell carcinoma (ccRCC). In this study, we determined the expression patterns of miR-217 in ccRCC, and tested its effect on cancer cell proliferation and migration. The expression levels of miR-217 were determined in 54 ccRCC samples using Real-Time qPCR. 786-O and ACHN cells were transfected with miR-217 mimics or miRNA mimics control. Cell proliferation and migration were evaluated by MTT assay and scratch-wound assay, respectively. We found that miR-217 was down-regulated in ccRCC compared to paired normal tissue. Lower miR-217 expression levels were associated with higher tumor grade and stage. All patients with high miR-217 expression survived 5 years, while with low miR-217 expression, only 40% survived. Cell proliferation inhibition and decreased motility were observed in cells transfected with the miR-217 mimics. In conclusion, miR-217 plays a tumor suppressor role in ccRCC.

摘要

异常表达的 microRNAs(miRNAs)与多种人类癌症密切相关,包括肾透明细胞癌(ccRCC)。在这项研究中,我们确定了 miR-217 在 ccRCC 中的表达模式,并测试了其对癌细胞增殖和迁移的影响。通过实时 qPCR 检测了 54 例 ccRCC 样本中的 miR-217 表达水平。将 miR-217 模拟物或 miRNA 模拟物对照转染到 786-O 和 ACHN 细胞中。通过 MTT 测定和划痕实验分别评估细胞增殖和迁移。与配对的正常组织相比,我们发现 miR-217 在 ccRCC 中下调。较低的 miR-217 表达水平与较高的肿瘤分级和分期相关。所有高 miR-217 表达的患者均存活 5 年,而低 miR-217 表达的患者中只有 40%存活。转染 miR-217 模拟物的细胞增殖受到抑制,迁移能力降低。综上所述,miR-217 在 ccRCC 中发挥肿瘤抑制作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验